You are here: Home > Investor Relations

 Investor Relations

 
 Recent Releases

 Archived Releases

 Analyst Coverage

 SEC Filings

 Transfer Agent

 Auditors

 Investor Package

 E-Mail Alerts

 
 Contact Us

4/29/2008 ELITE PHARMACEUTICALS APPOINTS CHIEF SCIENTIFIC OFFICER

3/31/2008 Elite Pharmaceuticals, Inc. Reports Opioid Abuse-Resistant Products Gaining Momentum
Elite Provides Update on Company’s Progress and Projected Milestones


3/3/2008 Elite Pharmaceuticals, Inc. to Present at the Susquehanna Financial Healthcare Conference

2/14/2008 Elite Pharmaceuticals, Inc. to Present Clinical Data at the American Academy of Pain Medicine’s 24th Annual Meeting

1/23/2008 Elite Pharmaceuticals, Inc. Retains The Global Consulting Group as Strategic Communications Advisors

More Releases...

Click Here for a complete archive


Elite Pharmaceuticals, Inc. 165 Ludlow Ave., Northvale, NJ 07647    Phone:  201-750-2646  Fax:  201-750-2755 
E Mail:  webmaster@elitepharma.com